Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Hachem
R
R
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Afif
C
C
Gokaslan
Z
Z
Raad
I
I
D000081:Acetamides / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000601:surgery; D002528:Cerebellar Neoplasms / Q000556:secondary / Q000601:surgery; D002555:Cerebrospinal Fluid / Q000378:metabolism / Q000382:microbiology; D016983:Enterococcus / Q000187:drug effects* / Q000254:growth & development; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology; D000069349:Linezolid; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D023303:Oxazolidinones / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D020713:Vancomycin Resistance; D014696:Ventriculostomy
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid